0 Σχόλια
0 Μοιράστηκε
60 Views
0 Προεπισκόπηση
Αναζήτηση
Ανακάλυψε νέους ανθρώπους, δημιούργησε νέες συνδέσεις και κάνε καινούργιους φίλους
-
Παρακαλούμε συνδέσου στην Κοινότητά μας για να δηλώσεις τι σου αρέσει, να σχολιάσεις και να μοιραστείς με τους φίλους σου!
-
Radiopharmaceutical Theranostics Market: Is 2026 the Year "Search and Destroy" Medicine Becomes the Standard of Care?As of January 23, 2026, the radiopharmaceutical theranostics market is identifying as the "fifth pillar" of cancer treatment, with its 2026 valuation projected to reach approximately $3.27 billion to $6.18 billion globally. The 2026 landscape is defined by a massive CAGR of up to 27.9%, driven by the clinical success of "Radioligand Therapies" that combine diagnostic imaging and therapeutic...0 Σχόλια 0 Μοιράστηκε 475 Views 0 Προεπισκόπηση
-
The Integration of Artificial Intelligence and Personalized Dosimetry in the Radiopharmaceutical MarketIn the realm of nuclear medicine, delivering a lethal dose of radiation to a tumor while sparing healthy organs is a delicate balancing act. Historically, radioligand therapies have been administered using a standardized, "one-size-fits-all" dosing approach based on a patient's body weight or surface area. However, as the Radiopharmaceutical Market matures, the industry is rapidly pivoting...0 Σχόλια 0 Μοιράστηκε 104 Views 0 Προεπισκόπηση